SR-THAP is a gamma-aminobutyric acid transporter 3 (GAT3) inhibitor with an IC50 of 4.9 µM, and exhibits 42-fold and 23-fold selectivity over GAT1 and GlyT1, respectively. SR-THAP inhibits GABA uptake in mammalian cells. SR-THAP is applicable to the research of epilepsy, Alzheimers disease and ischemic stroke[1].
Molekulargewicht:
517.61
CAS Nummer:
[3098361-74-8]
Formel:
C31H35NO6
Target-Kategorie:
GABA Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
